InvestorsHub Logo
Followers 224
Posts 32039
Boards Moderated 4
Alias Born 10/10/2005

Re: Turnthecameraon post# 6047

Wednesday, 05/05/2021 10:37:08 AM

Wednesday, May 05, 2021 10:37:08 AM

Post# of 6214
Vaxart recovers day after shares take post-earnings drubbing

May 04, 2021

By: Jonathan M Block, SA News Editor

Vaxart (NASDAQ:VXRT) shares are up more than 9.3% in late afternoon trading, a day after the stock dropped 26% due to disappointing Q1 earnings and a delay in a phase 2 trial of its oral COVID-19 vaccine candidate.
However, shares rose more than 20% after-hours yesterday as the company reported promising phase 1 results on the candidate in COVID-19 variants.

B. Riley analyst Mayank Mamtani today reiterated his buy rating and $13 price target.

He wrote that he is encouraged by the company's build-up of its manufacturing capabilities, as well as having some production tasks completed by partners.

Successful Trading is the art of minimizing long term risk and maximizing capital allocation.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VXRT News